Form 4: Vertex Pharmaceuticals EVP Charles F Wagner Jr. Reports Stock Disposal
SEC Form 4 Filing
Charles F Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 4,962 shares of common stock on February 26, 2025, to cover tax obligations.
Summary
- On February 26, 2025, Charles F Wagner Jr., the EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 4,962 shares of common stock.
- The transaction was executed at a price of $479.61 per share.
- Following the transaction, Wagner directly owns 54,969 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This transaction is likely related to tax obligations associated with stock-based compensation.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a routine disposal of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of stock disposal transaction |
| 02/28/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.